Mike L. Kovar
Analyst · Ike Boruchow with JPMorgan
Thanks, Kosta. I'll start off this morning by briefly touching on our first quarter 2012 versus 2011 results from this morning's press release. Net sales increased 9.8%, 11.1% on a constant dollar basis, to $590 million compared to $537 million. Gross profit increased 9% to $329 million, or 55.8% of net sales compared to $302 million, or 56.2% of net sales. Operating income decreased 10.5% to $83 million, or 14.1% of net sales compared to $93 million, or 17.2% of net sales. Net income attributable to Fossil increased 4.2% to $58 million compared to $56 million. And diluted earnings per share increased 8.1% to $0.93 on 62.5 million in shares outstanding compared to $0.86 per diluted share on 64.8 million shares outstanding. From a sales mix perspective, our Direct-to-Consumer business picked up a 160-basis-point increase from our Wholesale business and within our Wholesale business, Asia picked up a 110-basis-point increase, primarily from our European business. Specific to our wholesale operations, North American base sales, which include operating activities in the U.S., Canada and Mexico, as well as sales to our third-party distributor partners in South America, grew by $18 million, or 8.8%, to $225 million and excluding approximately $1 million from unfavorable currency comparisons to Q1 last year, North America Wholesale sales increased by 9.3%. Sales from our Europe Wholesale operations increased by $1 million, or 0.7%, to $153 million. Excluding FX that unfavorably impacted sales by $6 million, Europe Wholesale sales grew at 4.7%. Sales from our Asia Wholesale operations increased by $12 million, or 19.5%, to $77 million. And again, excluding currency that favorably impacted sales by about $400,000, Asia Wholesale sales grew by 18.8%. Specific to our Direct-to-Consumer business, sales increased by $21 million, or 18.1%, to $135 million; that included an unfavorable impact of about $700,000 from currency. And on a constant dollar basis, Direct-to-Consumer sales grew by 18.7%. Constant dollar comps in our retail stores were 7.7% in Q1, on top of a 21.3% increase in the prior year quarter. And this represents the 16th consecutive quarter of positive comps. Globally, we ended Q1 with 398 stores, 190 of which were outside of North America. And we occupied 700,000 square feet compared to 636,000 square feet at the end of Q1 last year, an increase of 10.1%. Our store base included 247 full-price accessory stores, 145 of which are outside of North America, 105 outlet locations including 30 outside of North America, 33 clothing stores with 4 outside of North America and 13 full-price multi-brand stores, with 11 of those outside of North America. This compares to 362 stores at the end of Q1 last year, of which 165 were located outside North America. This included 233 full-price accessory stores with 130 located outside of North America, 92 outlets including 23 outside North America, 27 clothing stores including 3 outside of North America and 10 full-price multi-brand stores with 9 of those outside of North America. During the first quarter, we opened 5 stores and closed 5 and as Kosta mentioned previously, we are currently on track to open an additional 65 to 70 stores by the end of the year. From a watch and non-watch category perspective, total watch sales increased $46 million or 12.3%, 13.7% excluding currency to $418 million, with FOSSIL brand watch sales increasing $10 million or 9.2%, 11% x currency to $119 million and licensed watch sales increasing by $43.3 million or 19.2%, 20.6% x currency to $269 million. While on the non-watch side of our business, leather product sales increased $13 million or 14.9%, 15.8% x currency to $104 million, jewelry sales decreased $3 million or 7.1%, 4.8% x currency to $39 million. And while the continued launch of Kors jewelry added $4 million, this was offset by a decline in our FOSSIL jewelry business. And eyewear product sales decreased $4.8 million or 26.8%, 25.6% x currency to $13.3 million. Gross profit increased to $329 million in the first quarter, a 9% increase in comparison to $302 million in the prior year quarter. Gross profit margin declined 40 basis points to 55.8% compared to 56.2% in Q1 last year. This decline was principally driven by an increase in the cost of factory labor and certain watch components and a higher percentage of sales to third-party distributors. Foreign currency rate changes negatively impacted gross profit margin by approximately 20 basis points for the quarter. Partially offsetting these negative influences on gross margin were increases in the sales mix of higher margin watch products, Direct-to-Consumer sales and Asia Pacific Wholesale sales in comparison to Q1 last year. For fiscal year 2012, we expect full year gross profit margins only slightly below the 56.1% level achieved in 2011. At prevailing exchange rates, currency will negatively impact gross margins on a full year basis, with a more severe impact on Q2 and Q3. Also in comparison to the prior year, Q2 margins will be impacted by input cost increases similar to that level expense in our first quarter, as we don't anniversary most of the production cost increases we absorbed last year until the second half of this year. However, select price increases and an expected higher mix of sales from our Asia Wholesale and Direct-to-Consumer segments will partially offset the impact of unfavorable currency comparisons and higher input costs. We do not expect the addition of the Skagen business for the balance of the year to have a material impact to our structural gross profit margin rate. However, at this time, we don't have a lot of visibility as to the quality of inventory being held in distributor markets. Operating expenses, expressed as a percentage of net sales, increased to 41.7% in Q1 compared to 39% in the prior year quarter. Total operating expenses in our Wholesale segment increased by $13.6 million, of which approximately $10 million of this was related to the Asia region, including the impact of the Asia infrastructure buildout and management additions, which primarily commenced after the first quarter last year. Expense increases of $14.2 million in our Direct-to-Consumer segment were primarily attributable to store growth, while corporate expense increases of $9.1 million were primarily attributable to increased payroll cost due to headcount additions and incentive stock compensation, as well as higher operating costs associated with our new corporate headquarters. For fiscal 2012, excluding transaction and other nonrecurring costs related to the integration transition of Skagen, we are expecting slight deleverage in operating expenses. This deleverage is more impactful in the first half of the year, as we want anniversary expenses associated with our new headquarters until the second half of the year and we're continuing to make investments in support of our long-term growth strategies in Asia. As a percentage of net sales, Q1 operating income decreased to 14.1% of net sales compared to 17.2% of net sales in the prior year quarter, primarily the result of decreases in both gross profit margin and operating expense leverage. During the first quarter, operating income was negatively impacted by approximately $3 million, as a result of currency translation. Other income and expense increased favorably by $5.6 million for the first quarter, and this increase was primarily driven by net foreign currency gains resulting from mark-to-market hedging and other transactional activities during Q1 compared to currency losses in the prior year quarter. Income tax expense for the first quarter was $23.5 million, resulting in an effective income tax rate of 27.8% and were favorably impacted by certain discrete items and the release of a $2.8 million deferred income tax liability associated with our decision to permanently reinvest certain past and future earnings related to specific subsidiaries in Asia. For the balance of fiscal year 2012, we estimate our effective tax rate will approximate 32%, excluding any additional discrete events. First quarter net income attributable to Fossil increased by 4.2% to $58.1 million, or $0.93 per diluted share compared to $55.8 million, or $0.86 per diluted share in the prior year quarter. Q1 was positively impacted by net currency gains of $0.03 per diluted share. Turning to the balance sheet. We ended the first quarter with cash, cash equivalents and securities available for sale totaling $261 million compared to $355 million at the end of Q1 last year, and we had roughly $21 million of debt. At the beginning of the second quarter, to fund the U.S. portion of the acquisition of Skagen, including amounts related to escrow requirements, we drew down approximately $200 million on our $350 million U.S. based revolving line of credit. And since that time, we have paid down approximately $25 million into that amount. Purchase price amount associated with the acquisition of Skagen subsidiaries located outside the U.S. were paid from excess cash in our Europe and Asia subsidiaries. Based upon our current cash flow estimates, we expect the majority of the current amount outstanding under our U.S. revolving line of credit to be repaid by the end of fiscal 2012. As of the date, since the inception of our $750 million buyback authorization in August of 2010, we have repurchased $532 million of common stock, representing approximately 7 million shares. Inventory at the end of the first quarter was $512 million, representing an increase of 27.2% in comparison to last year's Q1 balance of $403 million. This increase is primarily related to the shortfall of expected sales for the first quarter and increased levels of watch component inventories. As we've discussed in previous calls, we have increased the level of inventory related to key watch component parts, including those with longer lead times, given the concentration of certain vendors and given the experience we had with our movement supply in Japan, considering the natural disasters that occurred there early last year. Accounts receivable increased by 1.6% to $223 million at the end of Q1 compared to $220 million at the end of the prior year quarter. And first quarter day sales outstanding for our Wholesale segment was 43 days in comparison to 46 days in the prior-year quarter, and this decrease was primarily the result of lower sales increases in Europe that generally have longer collection cycles. During the first quarter, we had capital expenditures of approximately $18 million and are expecting fiscal year 2012 capital expenditures of approximately $120 million. The bulk of this CapEx spend is related to new store openings, a new POS and back-office system for our Asia retail stores, improvements to our product lifecycle management and demand planning systems and implementation of a new global financial planning and reporting system, as well as normal CapEx maintenance activity. Depreciation and amortization expense for the first quarter totaled $13 million. And we estimate full year 2012 depreciation and amortization of approximately $60 million. Turning to guidance for the balance of 2012. For the second quarter, we expect reported net sales to increase around 16%, with constant dollar net sales increasing 19%. Net sales of Skagen included in this estimate are expected to benefit overall sales growth by 6% during the quarter. Including Skagen activities, second quarter 2012 diluted earnings per share are expected to be in a range of $0.77 to $0.79. And while we expect Skagen to deliver approximately $0.03 of operational earnings for the second quarter, we're also expecting transition-related costs and other transition integration activities to negatively impact second quarter diluted earnings per share by approximately $0.07. For the full year, we expect reported net sales to increase approximately 16%, with constant dollar net sales increasing 18%. Net sales of Skagen included in this estimate are expected to benefit overall sales growth by 5%. For the full year, we expect diluted earnings per share in the range of $5.30 to $5.40. Within our full year earnings estimate, we are including $0.22 related to Skagen operational activities, partially offset by an expected $0.15 of diluted earnings per share related to transaction and other transition integration costs. Additionally, relative to our original guidance given in February, a stronger U.S. dollar is negatively impacting Q2 earnings by about $0.02 and the full year by $0.07. Our forward guidance is based upon the current prevailing rate of the U.S. dollar compared to other foreign currencies for countries in which we operate. And now, I'd like to turn the call over to the operator to begin the question-and-answer portion of the call.